Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA To Increase Stake in Regeneron Pharmaceuticals Inc-Reuters


Monday, 11 Feb 2013 02:29pm EST 

Reuters reported that Sanofi SA is to buy more shares in Regeneron Pharmaceuticals Inc. Sanofi controls 16.7% of Regeneron, or 15.82 million shares, according to Reuters data. Sanofi said in an email that it has the right to raise the stake to as much as 30% under its decade-long partnership with Regeneron. 

Company Quote

79.66
-0.93 -1.15%
5:48am EDT